注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   基因重组   >   Anti-ROR2 Reference Antibody (ozuriftamab vedotin)   

Anti-ROR2 Reference Antibody (ozuriftamab vedotin)

Recombinant Antibody

     
  • 0 - Anti-ROR2 Reference Antibody (ozuriftamab vedotin) APR10623
    Anti-ROR2 Reference Antibody (ozuriftamab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-ROR2 Reference Antibody (ozuriftamab vedotin) APR10623
    The purity of Anti-ROR2 Reference Antibody (ozuriftamab vedotin) is 99.74%, determined by SEC-HPLC.
  • 0 - Anti-ROR2 Reference Antibody (ozuriftamab vedotin) APR10623
    The drug-to-antibody ratio (DAR) of the Anti-ROR2 Reference Antibody (ozuriftamab vedotin) is 3.9.
  • 0 - Anti-ROR2 Reference Antibody (ozuriftamab vedotin) APR10623
    Immobilized ROR2 at 2 µg/mL (30 uL/well) can bind Anti-ROR2 Reference Antibody (ozuriftamab vedotin),EC50 is 0.160 ug/mL.
  • 0 - Anti-ROR2 Reference Antibody (ozuriftamab vedotin) APR10623
    Human ROR2 CHO-S Cell Line were stained with Anti-ROR2 Reference Antibody (ozuriftamab vedotin) and negative control protein respectively, washed and then followed by PE and analyzed with FACS,The EC50 is 0.2650 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession Q01974
Reactivity Human
Clonality ADC
Isotype IgG1
Calculated MW 104757 Da
Additional Information
Target/Specificity ROR2
Endotoxin < 0.001EU/ µg,determined by LAL method.
Conjugation MMAE
Expression system CHO
Format Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name ROR2
Synonyms NTRKR2
Function Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development (By similarity). Phosphorylates YWHAB, leading to induction of osteogenesis and bone formation (PubMed:17717073). In contrast, has also been shown to have very little tyrosine kinase activity in vitro. May act as a receptor for wnt ligand WNT5A which may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443).
Cellular Location Cell membrane; Single-pass type I membrane protein
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价